对于罕见瘤的管理组织和结构存在争议
Isabelle Ray-Coquard1, Jonathan Ledermann2, Anna DeFazio3
1Centre Léon Bérard, University Claude Bernard Lyon I, Lyon, France; Groupe d'Investigateurs Nationaux pour l'Étude des Cancers de l'Ovaire et du sein (GINECO).
概括
罕见的妇科癌症带来了重大的诊断和研究挑战. 合作网络和创新试验对于改善患者的治疗结果和推动这些罕见疾病的研究至关重要.
科学领域:
- 妇科瘤学 妇科瘤学
- 罕见的癌症 罕见的癌症
- 临床研究 临床研究
背景情况:
- 超过一半的妇科癌症是罕见的,存在诊断和管理困难.
- 罕见的癌症总体上构成了相当大的负担,超过了单个常见的癌症.
- 流行病学,组织学和生物学变异使基于证据的护理和研究变得复杂.
研究的目的:
- 突出诊断,管理和研究罕见妇科癌症的挑战.
- 讨论不断变化的分类和诊断变异的影响.
- 通过合作和创新的研究设计,探索改善成果的策略.
主要方法:
- 复习罕见妇科癌症管理和研究当前的挑战.
- 分析国际合作和联盟的作用.
- 讨论新的临床试验设计及其对罕见瘤的必要性.
主要成果:
- 罕见的妇科癌症需要集中的病理学和协调的标准,以有效管理.
- 专家中心的多学科护理改善了结果,但差异仍然存在.
- 国际合作和创新的试验设计正在推进研究和标准化护理.
结论:
- 综合集中的集中护理,创新的试验设计和国际网络的综合方法对于罕见的妇科癌症是必不可少的.
- 医疗保健的协调和加速的翻译研究是弥合创新和患者利益之间的差距的关键.
- 解决跨境合作和监管途径的挑战对于公平获得试验和治疗至关重要.
相关概念视频
Methods of Documentation VI: Case Management Model
559
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
559
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Cancer Survival Analysis
319
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
319


